Bicara Therapeutics Inc. (BCAX) Financial Statements
$17.07NGM: BCAXMarket Cap $1.13B
Bicara Therapeutics Inc. most recently reported annual revenue of $0, a net loss of $138.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Bicara Therapeutics Inc.: net profit was positive in 0 of 4 reported years; the most recent year shows a net loss of $138.0M.
Income Statement — 4 Years (USD millions)
Metric
2022
2023
2024
2025
Revenue
$0
$0
$0
$0
Operating Expenses
$38.0M
$40.0M
$82.0M
$156.0M
Operating Profit
$-38.0M
$-40.0M
$-82.0M
$-156.0M
Operating Margin
0.0%
0.0%
0.0%
0.0%
Other Income
$0
$-12.0M
$15.0M
$18.0M
Interest
$0
$0
$0
$0
Depreciation
$0
$0
$0
$0
Profit Before Tax
$-38.0M
$-52.0M
$-68.0M
$-138.0M
Tax
$0
$-10,000
$-280,000
$-160,000
Net Profit
$-38.0M
$-52.0M
$-68.0M
$-138.0M
EPS
$-0.73
$-1.00
$-1.25
$-2.52
Dividend Payout
0.0%
0.0%
0.0%
0.0%
Quarterly Results — Last 12 Quarters (USD millions)
2 duplicate period labels in the source data were collapsed.
Metric
Sep '23
Dec '23
Mar '24
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Revenue
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
Operating Expenses
$10.0M
$14.0M
$15.0M
$20.0M
$21.0M
$27.0M
$42.0M
$32.0M
$41.0M
$41.0M
$60.0M
$60.0M
Operating Profit
$-10.0M
$-14.0M
$-15.0M
$-20.0M
$-21.0M
$-27.0M
$-42.0M
$-32.0M
$-41.0M
$-41.0M
$-60.0M
$-60.0M
Operating Margin
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Interest
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
Profit Before Tax
$-23.0M
$-12.0M
$-13.0M
$-17.0M
$-17.0M
$-21.0M
$-37.0M
$-27.0M
$-36.0M
$-37.0M
$-56.0M
$-55.0M
Tax
$0
$-40,000
$-10,000
$0
$0
$-900,000
$-200,000
$-190,000
$-110,000
$-140,000
$90,000
$-110,000
Net Profit
$-23.0M
$-12.0M
$-13.0M
$-17.0M
$-17.0M
$-21.0M
$-37.0M
$-27.0M
$-36.0M
$-37.0M
$-56.0M
$-55.0M
EPS
$-0.42
$-0.23
$-0.27
$-0.27
$-0.32
$-0.38
$-0.68
$-0.50
$-0.67
$-0.68
$-0.93
$-0.82
Over the 4 years reported for Bicara Therapeutics Inc., cash stood at $97.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 14.55 times.
Balance Sheet — 4 Years (USD millions)
Metric
2022
2023
2024
2025
Total Assets
$7.0M
$234.0M
$569.0M
$431.0M
Current Assets
$5.0M
$231.0M
$503.0M
$422.0M
Cash
$4.0M
$230.0M
$490.0M
$97.0M
Inventory
$0
$0
$0
$0
Receivables
$0
$0
$0
$0
Fixed Assets
$1.0M
$1.0M
$1.0M
$2.0M
Capital Work in Progress
$0
$0
$0
$0
Investments
$0
$0
$0
$318.0M
Other Assets
$0
$0
$0
$0
Total Liabilities
$24.0M
$15.0M
$77.0M
$30.0M
Current Liabilities
$24.0M
$15.0M
$18.0M
$29.0M
Borrowings
$0
$1.0M
$1.0M
$2.0M
Other Liabilities
$24.0M
$15.0M
$77.0M
$28.0M
Equity
$0
$0
$0
$0
Reserves
$-17.0M
$219.0M
$492.0M
$401.0M
For Bicara Therapeutics Inc., operating cash flow was positive in 0 of 4 reported years; free cash flow in the latest year was negative at $107.0M; free cash flow was positive in 0 of 4 years.
Cash Flow Statement — 4 Years (USD millions)
Metric
2022
2023
2024
2025
Operating Cash Flow
$-32.0M
$-46.0M
$-75.0M
$-107.0M
Investing Cash Flow
$0
$-1.0M
$0
$-319.0M
Financing Cash Flow
$0
$0
$2.0M
$0
Net Cash Flow
$-1.0M
$226.0M
$259.0M
$-393.0M
Free Cash Flow
$-32.0M
$-46.0M
$-75.0M
$-107.0M
Valuation & Return Ratios
Metric
Value
PEG Ratio
0.14
EV / EBITDA
-6.13
FCF Yield
-11.03%
Quick Ratio
11.59
Interest Coverage
—
Return 1Y
135.20%
Return 3Y
—
Return 5Y
—
Bicara Therapeutics Inc. (BCAX) financials — frequently asked questions
What is Bicara Therapeutics Inc.'s annual revenue?
Bicara Therapeutics Inc. (BCAX) reported annual revenue of $0 in its most recent fiscal year.
What is Bicara Therapeutics Inc.'s net profit?
Bicara Therapeutics Inc. (BCAX) reported a net loss of $138.0M in its most recent fiscal year.
What is BCAX EV/EBITDA?
Bicara Therapeutics Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is -6.13. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.